IBB - iShares Biotechnology ETF

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U. S.

As of Nov 13, 2026: spot at $212.56, ATM IV 24.1%, max pain $205.00, GEX (assumed dealer book) -$325.6K of delta per 1% move.

Exposures are the assumed dealer book over the expirations within 30 days of the session, or the first four when none are (1 expiration, through Nov 20, 2026), as of Nov 13, 2026. Assumes dealers are long the calls and short the puts, a share p of open interest each - here 100% of open interest (the GEX page sets the share). A date without a stored exposure is a gap; a value marked * is partial, averaged over fewer days, or may include contracts expiring that day or of an unreadable expiration: its reason is printed beside it.

Sector
Financial Services
Industry
Asset Management
Market Cap
$11.09B
Beta
0.70
52-Week Range
159.68-222.29
Dividend Yield
$0.34
IPO Date
Feb 12, 2001
Exchange
NASDAQ

What IBB Looks Like to Options Traders Today

IV rank of 37.7% sits near the 1-year median, where strategy choice depends on directional conviction and the event calendar rather than vol regime alone; the assumed dealer book's GEX is negative (-$325.6K of delta per 1% move): its hedging goes with the trend, amplifying realized volatility and accelerating directional moves where real dealers are positioned like the book; the 25-delta skew (0.026) prices calls richer than puts, often reflecting upside speculation or squeeze risk.

What This Page Covers

The IBB overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure.

IBB fund facts: expense ratio 0.44%, assets under management $11.15B, NAV $213.57 as of the data source's update on Nov 13, 2026, 246 holdings in its latest file, launched Feb 5, 2001, issued by IShares. See the IBB holdings.

Frequently asked IBB overview questions

What is IBB?
IBB is the ticker symbol for iShares Biotechnology ETF, an listed exchange-traded fund. The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U. Listed on NASDAQ. IBB is the ETF ticker shown on this page; ETF traders use the fund for diversified exposure to its underlying basket, for sector and factor rotation, and for hedging or replication strategies via the listed options chain.
What does the IBB options snapshot look like today?
As of Nov 13, 2026, the IBB options snapshot shows spot at $212.56, ATM IV 24.1%, IV rank 37.7%, max pain $205.00, GEX (assumed dealer book) -$325.6K of delta per 1% move, expected move 6.91%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, the assumed dealer book's gamma exposure and the put-minus-call delta balance, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
What are IBB's key statistics?
iShares Biotechnology ETF (IBB) carries a market capitalization of $11.09B, 52-week range of 159.68-222.29. Full holdings disclosure, expense ratio, and tracking-error history live on the per-ticker fundamentals page or the sponsor's site; daily NAV and premium/discount-to-NAV are accessible from the same view. These structural inputs frame how the ETF options market prices implied volatility relative to its constituents.
What sector or industry does IBB belong to?
iShares Biotechnology ETF operates in the Financial Services sector, in the Asset Management industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare IBB's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
How current is the IBB data on this page?
The options snapshot above is dated Nov 13, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Fund-level fields (sponsor, expense ratio, holdings concentration where available) refresh from the vendor feed nightly. ETF-specific filings (N-CSR, N-PX, N-CEN) update on the SEC EDGAR cadence. FINRA microstructure data refreshes on the source's cadence; for ETFs the off-exchange volume signal is dominated by authorized-participant creation and redemption rather than directional flow.